In Gln-treated rats, lung Hsp72 and HSF1-p expressions were enhanced [32, 92], lung HMGB1 expression and NF-κB DNA-binding activity were suppressed, and ARDS was attenuated and survival improved [33]. The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.